BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$140M |
| 2 |
iShares US Financials ETF
IYF
|
+$119M |
| 3 |
AGN
Allergan plc
AGN
|
+$100M |
| 4 |
Charter Communications
CHTR
|
+$95.1M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$82.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.2B |
| 2 |
State Street SPDR S&P Biotech ETF
XBI
|
+$909M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$623M |
| 4 |
Apple
AAPL
|
+$389M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$369M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.73% |
| 2 | Financials | 5.47% |
| 3 | Healthcare | 4.96% |
| 4 | Consumer Discretionary | 4.64% |
| 5 | Industrials | 3.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3226
Akebia Therapeutics
AKBA
$241M
| $88.2K | ﹤0.01% |
13,952
-4,822
| -26% | -$22.9K |
|
3227
Goldgroup Mining Inc.
GORO
$211M
| $88.1K | ﹤0.01% |
15,904
+5,916
| +59% | +$25.8K |
|
|
EXTN
3228
DELISTED
Exterran Corporation
EXTN
| $88K | ﹤0.01% |
11,238
+5,412
| +93% | +$50.2K |
|
3229
Civista Bancshares
CIVB
$595M
| $87.8K | ﹤0.01% |
3,659
+1,385
| +61% | +$30.7K |
|
3230
CRA International
CRAI
$1.07B
| $87.8K | ﹤0.01% |
1,612
+343
| +27% | +$16.7K |
|
3231
Sportsman's Warehouse
SPWH
$46.8M
| $87.1K | ﹤0.01% |
10,846
+4,619
| +74% | +$32.7K |
|
3232
Quince Therapeutics
QNCX
$33M
| $87.1K | ﹤0.01% |
8
+6
| +300% | +$36.2K |
|
3233
Luxfer Holdings
LXFR
$457M
| $87K | ﹤0.01% |
4,700
-178
| -4% | -$3.06K |
|
|
BNFT
3234
DELISTED
Benefitfocus, Inc.
BNFT
| $86.7K | ﹤0.01% |
3,950
-1,227
| -24% | -$27.8K |
|
|
RST
3235
DELISTED
ROSETTA STONE INC
RST
| $86.5K | ﹤0.01% |
4,768
+1,573
| +49% | +$26.8K |
|
3236
FRP Holdings
FRPH
$425M
| $86K | ﹤0.01% |
3,452
+1,168
| +51% | +$29.4K |
|
|
YMAB
3237
DELISTED
Y-mAbs Therapeutics
YMAB
| $85.8K | ﹤0.01% |
2,744
-64
| -2% | -$1.89K |
|
3238
Daily Journal
DJCO
$828M
| $85.7K | ﹤0.01% |
295
+101
| +52% | +$28.2K |
|
3239
Tucows
TCX
$134M
| $85.6K | ﹤0.01% |
1,386
-126
| -8% | -$7.18K |
|
|
RVNC
3240
DELISTED
Revance Therapeutics, Inc.
RVNC
| $85.4K | ﹤0.01% |
5,261
-1,094
| -17% | -$17K |
|
3241
VanEck Vietnam ETF
VNM
$506M
| $85.1K | ﹤0.01% |
5,321
+2,146
| +68% | +$34.6K |
|
|
REVG
3242
DELISTED
REV Group
REVG
| $84.9K | ﹤0.01% |
6,943
+1,826
| +36% | +$23.1K |
|
3243
Peoples Financial Services
PFIS
$717M
| $84.7K | ﹤0.01% |
1,683
+567
| +51% | +$27.7K |
|
|
DERM
3244
DELISTED
Dermira, Inc.
DERM
| $84.4K | ﹤0.01% |
5,567
-542
| -9% | -$4.68K |
|
3245
TETRA Technologies
TTI
$1.25B
| $84.2K | ﹤0.01% |
42,943
+23,111
| +117% | +$37.2K |
|
3246
Digital Turbine
APPS
$1.53B
| $84.1K | ﹤0.01% |
11,793
+2,018
| +21% | +$15K |
|
3247
UroGen Pharma
URGN
$2.34B
| $83.2K | ﹤0.01% |
2,493
-866
| -26% | -$23.6K |
|
|
HCCI
3248
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
| $83.1K | ﹤0.01% |
2,650
+249
| +10% | +$7.12K |
|
|
NPTN
3249
DELISTED
NEOPHOTONICS CORP
NPTN
| $83.1K | ﹤0.01% |
9,422
+3,536
| +60% | +$26.5K |
|
|
KDMN
3250
DELISTED
Kadmon Holdings, Inc.
KDMN
| $83K | ﹤0.01% |
18,320
+1,028
| +6% | +$3.76K |
|
Similar funds
BNP Paribas Financial Markets's Q4 2019 Portfolio in Review
As of Q4 2019, BNP Paribas Financial Markets held 4,613 positions worth $54.9B, down 2.5% from $56.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
BNP Paribas Financial Markets withdrew a net $10.1B in Q4 2019, closing 185 positions and reducing 1,420 holdings. Its most notable exit was Celgene Corp, an estimated $56.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.3% a quarter earlier, followed by Financials and Healthcare.
Against the trend, BNP Paribas Financial Markets opened a new position in iShares US Financials ETF worth $124M.
- BNP Paribas Financial Markets's largest Q4 2019 buy was iShares US Financials ETF: 1,800,000 shares worth $124M.
- BNP Paribas Financial Markets added most to Bristol-Myers Squibb in Q4 2019, an estimated $140M increase.
- BNP Paribas Financial Markets's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.2B.
- BNP Paribas Financial Markets fully exited Celgene Corp in Q4 2019, selling an estimated $56.8M.
- BNP Paribas Financial Markets's ten largest holdings make up 16% of its $54.9B portfolio in Q4 2019.
- BNP Paribas Financial Markets opened 106 new positions and closed 185 in Q4 2019.
- BNP Paribas Financial Markets's portfolio value fell 2.5% quarter-over-quarter to $54.9B.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2019, filed 12 Feb 2020.